Novel treatments for melanoma over the past decade have dramatically enhanced survival. Immune checkpoint inhibitors and BRAF/MEK inhibitors have both demonstrated significant improvements in melanoma patient outcomes as demonstrated by many clinical trials. Unfortunately, patients who develop brain metastases still carry a grim prognosis, with a median overall survival of fewer than 6 months. Additionally, there is relatively […]
Grumbach collaboration to examine impact of radiation on blood vessels
Isabella Grumbach, MD, PhD, professor in Cardiovascular Medicine, and Randy Kardon, MD, PhD, professor of Ophthalmology and Visual Sciences, received a five-year, R01 grant for $2.5 million from the National Institutes of Health. The duo will study the effects of radiation therapy on small blood vessels, also known as microvessels, in cancer survivors. Every year, […]